Market Research Life Sciences Market Research Biotechnology Market Research Cell Culture Market Research

Non-Animal Alternatives Testing Global Market Opportunities And Strategies To 2032

Best Price Guarantee Length Publisher Published Date SKU
from $5,000 367 Pages The Business Research Company May, 2023 BRC17954974
Best Price Guarantee
Price from $5,000
Length 367 Pages
Publisher The Business Research Company
Published Date May, 2023
SKU BRC17954974

Non-Animal Alternatives Testing Global Market Opportunities And Strategies To 2032

Including: 1) By Technology: Cell Culture Technology; High Throughput Technology; Molecular Imaging; Omics Technology2) By Method: Cellular Assay; Biochemical Assay; In Silico; Ex-Vivo3) By End-User: Pharmaceutical Industry; Cosmetics And Household Products; Diagnostics; Chemicals Industry; Food And Beverage IndustryCovering: Evotec SE (Cyprotex); Bio-Rad Laboratories, Inc; BioIVT; Emulate, Inc; MatTek Corporation"


Non-Animal Alternatives Testing Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global non-animal alternatives testing market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Description:

Where is the largest and fastest-growing market for non-animal alternatives testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The non-animal alternatives testing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider non-animal alternatives testing market; and compares it with other markets.

The report covers the following chapters
  • Introduction and Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about the non-animal alternatives testing market.
  • Key Trends
Highlights the major trends shaping the global non-animal alternatives testing market. This section also highlights likely future developments in the market.
  • Global Market Size and Growth
Global historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis
Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region.
  • Market Segmentation
Contains the market values (2017-2032) and analysis for each segment by technology, by method and by end-user in the market.
  • Regional Market Size and Growth
Regional market size (2022), historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Key Mergers and Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies
Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations
This section includes recommendations for non-animal alternatives testing providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:
1) By Technology: Cell Culture Technology; High Throughput Technology; Molecular Imaging; Omics Technology; Other Technologies
2) By Method: Cellular Assay; Biochemical Assay; In Silico; Ex-Vivo
3) By End-User: Pharmaceutical Industry; Cosmetics And Household Products; Diagnostics; Chemicals Industry; Food And Beverage Industry; Other End Users


Companies Mentioned: Evotec SE (Cyprotex); Bio-Rad Laboratories, Inc; BioIVT; Emulate, Inc; MatTek Corporation
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; non-animal alternatives testing indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction And Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Non-Animal Alternatives Testing Market Definition And Segmentations
6.4. Market Segmentation By Technology
6.4.1. Cell Culture Technology
6.4.2. High Throughput Technology
6.4.3. Molecular Imaging
6.4.4. Omics Technology
6.4.5. Other Technologies
6.5. Market Segmentation By Method
6.5.1. Cellular Assay
6.5.2. Biochemical Assay
6.5.3. In Silico
6.5.4. Ex-Vivo
6.6. Market Segmentation By End-User
6.6.1. Pharmaceutical Industry
6.6.2. Cosmetics And Household Products
6.6.3. Diagnostics
6.6.4. Chemicals Industry
6.6.5. Food And Beverage Industry
6.6.6. Other End-Users
7. Major Market Trends
7.1. Developments In OOC (Organ-On-Chip) For Testing
7.2. Adoption Of In Silico Trials
7.3. Use Of Model Organisms
7.4. Focus On 3D-Printed Organs For Testing
7.5. Increasing Collaborations And Partnerships To Reduce Animal Testing
7.6. Rising Initiatives And Grants To Promote Animal-Free Testing
8. Global Market Size and Growth
8.1. Market Size
8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)
8.2.1. Market Drivers 2017 – 2022
8.2.2. Market Restraints 2017 – 2022
8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
8.3.1. Market Drivers 2022 – 2027
8.3.2. Market Restraints 2022 – 2027
9. Global Non-Animal Alternatives Testing Market Segmentation
9.1. Global Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.2. Global Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.3. Global Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10. Non-Animal Alternatives Testing Market, Regional and Country Analysis
10.1. Global Non-Animal Alternatives Testing Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10.2. Global Non-Animal Alternatives Testing Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.4. Asia-Pacific Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.5. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.6. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.7. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.8. Asia-Pacific Non-Animal Alternatives Testing Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes Levied
11.11.9. Corporate tax structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.13. China Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.14. China Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.15. China Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.16. China Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.17. India Market
11.18. India Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.19. India Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.20. India Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.21. India Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.22. India Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.23. Japan Market
11.24. Japan Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.25. Japan Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.26. Japan Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.27. Japan Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.28. Japan Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.29. Australia Market
11.30. Australia Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.31. Australia Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.32. Australia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.33. Australia Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.34. Australia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.37. Indonesia Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.38. Indonesia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.39. Indonesia Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.40. Indonesia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.43. South Korea Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.44. South Korea Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.45. South Korea Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.46. South Korea Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.4. Western Europe Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.5. Western Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.6. Western Europe Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.7. Western Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.8. Western Europe Non-Animal Alternatives Testing Market: Country Analysis
12.9. UK Market
12.10. UK Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.11. UK Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.12. UK Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.13. UK Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.14. UK Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.15. Germany Market
12.16. Germany Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.17. Germany Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.18. Germany Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.19. Germany Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.20. Germany Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.21. France Market
12.22. France Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.23. France Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.24. France Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.25. France Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.26. France Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.4. Eastern Europe Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.5. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.6. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.7. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.8. Eastern Europe Non-Animal Alternatives Testing Market: Country Analysis
13.9. Russia Market
13.10. Russia Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.11. Russia Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.12. Russia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.13. Russia Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.14. Russia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.4. North America Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.5. North America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.6. North America Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.7. North America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.8. North America Non-Animal Alternatives Testing Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.13. USA Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.14. USA Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.15. USA Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.16. USA Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Major Companies
15.3. South America Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.4. South America Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.5. South America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.6. South America Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.7. South America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.8. South America Non-Animal Alternatives Testing Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.11. Brazil Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.12. Brazil Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.13. Brazil Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.14. Brazil Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
16.4. Middle East Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
16.5. Middle East Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.6. Middle East Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.7. Middle East Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Major Companies
17.3. Africa Non-Animal Alternatives Testing Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
17.4. Africa Non-Animal Alternatives Testing Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
17.5. Africa Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.6. Africa Non-Animal Alternatives Testing Market, Segmentation By Method, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.7. Africa Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape and Company Profiles
19. Company Profiles
19.1. Evotec SE
19.1.1. Company Overview
19.1.2. Products And Services
19.1.3. Business Strategy
19.1.4. Financial Overview
19.2. Bio-Rad Laboratories Inc
19.2.1. Company Overview
19.2.2. Products And Services
19.2.3. Business Strategy
19.2.4. Financial Overview
19.3. BioIVT
19.3.1. Company Overview
19.3.2. Products And Services
19.3.3. Business Strategy
19.3.4. Financial Overview
19.4. Emulate, Inc
19.4.1. Company Overview
19.4.2. Products And Services
19.4.3. Business Strategy
19.4.4. Financial Overview
19.5. MatTek Corporation
19.5.1. Company Overview
19.5.2. Products And Services
19.5.3. Business Strategy
19.5.4. Financial Overview
20. Key Mergers And Acquisitions
20.1. AnaBios Acquired Cell Systems
20.2. Molecular Devices LLC Acquired Cellesce Ltd.
20.3. Angus Chemical Company Acquired Expression Systems
20.4. Cytiva Acquired CEVEC Pharmaceuticals
20.5. Evotec Acquired Rigenerand
20.6. SenzaGen Acquired VitroScreen S.r.l.
20.7. Bico Group Acquired HUREL Micro Liver Technologies
20.8. Bruker Acquired Canopy Biosciences, LLC
20.9. Sartorius Acquired Xell AG
20.10. Bio-Techne Acquired Asuragen Inc.
20.11. PerkinElmer Acquired Immunodiagnostic Systems Holdings PLC
20.12. Agilent Acquired Resolution Bioscience
20.13. Certara Acquired Silico Biosciences Inc.
21. Opportunities And Strategies
21.1. Global Non-Animal Alternatives Testing Market In 2027 – Countries Offering Most New Opportunities
21.2. Global Non-Animal Alternatives Testing Market In 2027 – Segments Offering Most New Opportunities
21.3. Global Non-Animal Alternatives Testing Market In 2027 – Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Non-Animal Alternatives Testing Market, Conclusions And Recommendations
22.1. Conclusions
22.2. Recommendations
22.2.1. Product
22.2.2. Place
22.2.3. Price
22.2.4. Promotion
22.2.5. People
23. Appendix
23.1. Market Data Sources
23.2. Research Methodology
23.3. Currencies
23.4. The Business Research Company
23.5. Copyright and Disclaimer

$5,000
$7,500
$10,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings